The US Food and Drug Administration (FDA) has approved the first drug to be used in early stage breast cancer treatment. Perjeta (pertuzumab) will be used as part of a complete treatment regimen for patients before surgery (neoadjuvant setting)...
- Patients
- Genetic Testing
- Professionals
- General Information About Breast Cancer
- Cellular Classification of Breast Cancer
- Stage Information for Breast Cancer
- Ductal Carcinoma In Situ (DCIS)
- Lobular Carcinoma In Situ (LCIS)
- Stage I, II, IIIA, and Operable IIIC Breast Cancer
- Stage IIIB, Inoperable IIIC, IV, Recurrent, and Metastatic Breast Cancer
- Breast implants and cancer risks (professionals)
- Local resources
- Events
- News
- Radiotherapy
- Feedback
- Contact us
- Privacy policy
- Follow Us!
